SBL
TBIO

Sargent Bickham Lagudis’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Sargent Bickham Lagudis’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$1K – 1020
2021
Q2 		$1K Hold
50
– – ﹤0.01% 917
2021
Q1 		$1K Hold
50
– – ﹤0.01% 926
2020
Q4 		$1K Buy
+50
New +$895 ﹤0.01% 862

Sargent Bickham Lagudis's TBIO Position: Q3 2021 in Review

Sargent Bickham Lagudis sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 50 shares — an estimated $1K sold.

Sargent Bickham Lagudis first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Sargent Bickham Lagudis reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 50 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Sargent Bickham Lagudis first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Sargent Bickham Lagudis's Translate Bio, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2021, filed 5 Nov 2021.